Complete Guide to EU Funding for MedTech Startups in 2025
From EIC grants to EIB loans and InvestEU guarantees — a practical overview of every EU instrument available to European health technology companies.
European MedTech companies have access to an unprecedented range of EU funding instruments in 2025. This guide maps the full landscape from pre-seed grant to growth equity, with practical eligibility criteria.
Grants (Non-Dilutive)
EIC Pathfinder (€2M–€3M): For exploratory research on breakthrough health technologies. Ideal for university spinouts and early-stage R&D companies. 2025 specific challenge: "AI-enhanced personalised medicine."
EIC Transition (€2.5M–€3.5M): Bridges the gap between lab proof-of-concept and market-ready prototype. Requires prior EIC Pathfinder or ERC grant. MedTech-specific call in Spring 2025.
EIC Accelerator (€0.5M–€2.5M grant + up to €15M equity): The flagship grant+equity instrument for innovative SMEs. 2025 health priorities include rare diseases, antimicrobial resistance, and digital mental health.
EU4Health Programme (€50K–€5M): Cross-border health system challenges. Specifically targets health data interoperability, rare disease registries, and pandemic preparedness.
Related Articles
Looking for EU Funding?
Finnova Foundation can help you identify the best funding calls for your project.
Get in touch →